O'Brien T - Search Results

1

Targeting stromal cell Syndecan-2 reduces breast tumour growth, metastasis and limits immune evasion.

Loftus PG, Watson L, Deedigan LM, Camarillo-Retamosa E, Dwyer RM, O'Flynn L, Alagesan S, Griffin M, O'Brien T, Kerin MJ, Elliman SJ, Barkley LR. Loftus PG, et al. Int J Cancer. 2021 Mar 1;148(5):1245-1259. doi: 10.1002/ijc.33383. Epub 2020 Dec 2. Int J Cancer. 2021. PMID: 33152121 Free PMC article.

2

Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells.

Dwyer RM, Potter-Beirne SM, Harrington KA, Lowery AJ, Hennessy E, Murphy JM, Barry FP, O'Brien T, Kerin MJ. Dwyer RM, et al. Clin Cancer Res. 2007 Sep 1;13(17):5020-7. doi: 10.1158/1078-0432.CCR-07-0731. Clin Cancer Res. 2007. PMID: 17785552

3

Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model.

Mohr A, Lyons M, Deedigan L, Harte T, Shaw G, Howard L, Barry F, O'Brien T, Zwacka R. Mohr A, et al. J Cell Mol Med. 2008 Dec;12(6B):2628-43. doi: 10.1111/j.1582-4934.2008.00317.x. Epub 2008 Mar 28. J Cell Mol Med. 2008. PMID: 18373740 Free PMC article.

4

Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells.

Molloy AP, Martin FT, Dwyer RM, Griffin TP, Murphy M, Barry FP, O'Brien T, Kerin MJ. Molloy AP, et al. Int J Cancer. 2009 Jan 15;124(2):326-32. doi: 10.1002/ijc.23939. Int J Cancer. 2009. PMID: 19003962

5

Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT).

Martin FT, Dwyer RM, Kelly J, Khan S, Murphy JM, Curran C, Miller N, Hennessy E, Dockery P, Barry FP, O'Brien T, Kerin MJ. Martin FT, et al. Breast Cancer Res Treat. 2010 Nov;124(2):317-26. doi: 10.1007/s10549-010-0734-1. Epub 2010 Jan 20. Breast Cancer Res Treat. 2010. PMID: 20087650

6

Genetically modified mesenchymal stem cells and their clinical potential in acute cardiovascular disease.

Griffin M, Greiser U, Barry F, O'Brien T, Ritter T. Griffin M, et al. Discov Med. 2010 Mar;9(46):219-23. Discov Med. 2010. PMID: 20350488 Free article. Review.

7

Advances in mesenchymal stem cell-mediated gene therapy for cancer.

Dwyer RM, Khan S, Barry FP, O'Brien T, Kerin MJ. Dwyer RM, et al. Stem Cell Res Ther. 2010 Aug 9;1(3):25. doi: 10.1186/scrt25. Stem Cell Res Ther. 2010. PMID: 20699014 Free PMC article. Review.

8

Differential miRNA expression in omental adipose tissue and in the circulation of obese patients identifies novel metabolic biomarkers.

Heneghan HM, Miller N, McAnena OJ, O'Brien T, Kerin MJ. Heneghan HM, et al. J Clin Endocrinol Metab. 2011 May;96(5):E846-50. doi: 10.1210/jc.2010-2701. Epub 2011 Mar 2. J Clin Endocrinol Metab. 2011. PMID: 21367929

9

Developing cell-specific antibodies to endothelial progenitor cells using avian immune phage display technology.

Bowes T, Hanley SA, Liew A, Eglon M, Mashayekhi K, O'Kennedy R, Barry F, Taylor WR, O'Brien T, Griffin MD, Finlay WJ, Greiser U. Bowes T, et al. J Biomol Screen. 2011 Aug;16(7):744-54. doi: 10.1177/1087057111407067. Epub 2011 May 18. J Biomol Screen. 2011. PMID: 21593485

10

Mesenchymal Stem Cell-mediated delivery of the sodium iodide symporter supports radionuclide imaging and treatment of breast cancer.

Dwyer RM, Ryan J, Havelin RJ, Morris JC, Miller BW, Liu Z, Flavin R, O'Flatharta C, Foley MJ, Barrett HH, Murphy JM, Barry FP, O'Brien T, Kerin MJ. Dwyer RM, et al. Stem Cells. 2011 Jul;29(7):1149-57. doi: 10.1002/stem.665. Stem Cells. 2011. PMID: 21608083 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,515 results

Search Page

Filters